Status:
ACTIVE_NOT_RECRUITING
Holter of Movement in Patients with Multiple Sclerosis in Uncontrolled Environment.
Lead Sponsor:
Centre Hospitalier Universitaire de Liege
Collaborating Sponsors:
SYSNAV
Centre Hospitalier Régional de la Citadelle
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
ActiSEP is a multicentric academic study. Ambulant patients with multiple sclerosis may be included on a voluntary basis. The investigators plan to include a group of approximately 80 patients with MS...
Eligibility Criteria
Inclusion
- Confirmed MS diagnosis,
- Over 18 years old,
- Ambulant patients,
- Signed informed consent,
- No clinical and / or radiological relapse within 3 months.
- EDSS \< or = à 5,5,
- Treated patient must be on a stable regimen dose and molecule for at least 2 month prior to inclusion.
Exclusion
- Patients with excessive cognitive disorders, limiting the understanding of task or with apparent communication difficulties hindering data collection.
- Any other previous or present pathology having an impact on motor function.
- Recent surgery or trauma (less than 6 months) in the upper or lower limbs
Key Trial Info
Start Date :
March 9 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 15 2026
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04882891
Start Date
March 9 2021
End Date
February 15 2026
Last Update
February 12 2025
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire de Liège
Liège, Liège, Belgium, 4000
2
CHR Citadelle
Liège, Liège, Belgium, 4000
3
Antwerp University Hospital
Antwerp, Belgium, 2000
4
CHC Mont Legia
Liège, Belgium, 4000